• Biogen to Present New Results for Spinraza, Other Treatments for Neurological Diseases
  • Harvard Team Finds Compound to Restore Protein That Is Short in SMA
  • Welcome to ‘Embracing My Inner Alien,’ a Column by Kevin Schaefer
  • Illness Becomes Chronic, But I’m Taking ‘My Shot’
  • Genentech Considering Design of Phase 3 Clinical Trial for SMA Therapy
  • Stanford, LPCH Plan 3rd Annual Spinal Muscular Atrophy Educational Conference for May 13
  • SMA Community and FDA to Meet in Washington Area on New Therapy Development
  • Study Reveals Views of SMA Patients and Families About Genetic Screening
  • Some Progress, but Fear of the Bronchoscopy That’s Coming
  • AveXis’ AVXS-101 Shows Promise in Treating Infants with SMA Type 1
  • Canadian Researcher Gets $140,000 Grant to Investigate Protein’s Regulation in SMA
  • Eating a Monster Meal with Friends